Views

CrossRef citations to date

Altmetric

Original Articles: Clinical

Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation

Heather LandauMemorial Sloan Kettering Cancer Center, New York, NY, USA; ;Weill Cornell Medical Center, New York, NY, USA; Correspondence[email protected]

Kevin WoodUniversity of Chicago, Chicago, IL, USA

David J. ChungMemorial Sloan Kettering Cancer Center, New York, NY, USA; ;Weill Cornell Medical Center, New York, NY, USA;

Guenther KoehneMemorial Sloan Kettering Cancer Center, New York, NY, USA; ;Weill Cornell Medical Center, New York, NY, USA;

Nikoletta LendvaiMemorial Sloan Kettering Cancer Center, New York, NY, USA; ;Weill Cornell Medical Center, New York, NY, USA;

Hani HassounMemorial Sloan Kettering Cancer Center, New York, NY, USA; ;Weill Cornell Medical Center, New York, NY, USA;

Alexander LesokhinMemorial Sloan Kettering Cancer Center, New York, NY, USA; ;Weill Cornell Medical Center, New York, NY, USA;

Elizabeth HooverMemorial Sloan Kettering Cancer Center, New York, NY, USA;

Junting ZhengMemorial Sloan Kettering Cancer Center, New York, NY, USA;

Sean M. DevlinMemorial Sloan Kettering Cancer Center, New York, NY, USA;

Sergio GiraltMemorial Sloan Kettering Cancer Center, New York, NY, USA; ;Weill Cornell Medical Center, New York, NY, USA;

show all

Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation

Supplementary Figure 1. Daily symptom scores for study patients from day -2 through engraftment.

Supplementary Figure 2. Median symptom scores at baseline, nadir, engraftment, and day +30 for study (protocol) and control patients (MM).

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

Supplementary Table 1: Symptom area under the curve (AUC) by 30 days in study and control patients.

Supplementary Table 2: Absolute difference in symptom score calculated as change from baseline for study and control patients.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation

Supplementary Figure 1. Daily symptom scores for study patients from day -2 through engraftment.

Supplementary Figure 2. Median symptom scores at baseline, nadir, engraftment, and day +30 for study (protocol) and control patients (MM).

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

ICMJE Form for Disclosure of Potential Conflicts of Interest

Supplementary Table 1: Symptom area under the curve (AUC) by 30 days in study and control patients.

Supplementary Table 2: Absolute difference in symptom score calculated as change from baseline for study and control patients.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date